CLIP CHAMP

Brand Owner (click to sort) Address Description
CLIPCHAMP Microsoft Corporation One Microsoft Way Redmond WA 98052 CLIP CHAMP;Software as a service (SAAS) services, namely, hosting software for use by others for use to capture videos, to process videos, and to convert videos; Providing a website featuring technology that enables users to capture video and convert video to MP4 or other compressed video formats;
CLIPCHAMP Clipchamp IP Pty Ltd TC Beirne Centre 3 02 (Level 3) 315 Brunswick Street Fortitude Valley 4006 Australia CLIP CHAMP;Software as a service (SAAS) services, namely, hosting software for use by others for use to capture videos, to process videos, and to convert videos; Providing a website featuring technology that enables users to capture video and convert video to MP4 or other compressed video formats;
CLIPCHAMP CLIPCHAMP PTY LTD 32 MORE STREET KELVIN GROVE 4059 Australia CLIP CHAMP;Software as a service (SAAS) services, namely, hosting software for use by others for use to capture videos, to process videos, and to convert videos; Providing a website featuring technology that enables users to capture video and convert video to MP4 or other compressed video formats;
CLIPCHAMP zfaas Pty Ltd c/o Alexander Dreiling 32 More Street Kelvin Grove QLD4057 Australia CLIP CHAMP;Software as a service (SAAS) services, namely, hosting software for use by others for use to capture videos, to process videos, and to convert videos; Providing a website featuring technology that enables users to capture video and convert video to MP4 or other compressed video formats;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to a new polypeptide and the gene encoding therefore, said gene being regulated in cardiac tissue by the transcription factor MEF2C. This polypeptide, CHAMP (cardiac helicase activated by MEF2 protein), bears striking resemblance to a number of other helicase proteins and appears to play a role in RNA processing and transcriptional control in heart muscle. For example, CHAMP has been demonstrated to inhibit both hypertrophy of primary cardiomyocytes and proliferation of non-cardiac cells. Also disclosed are methods of using the gene and protein in drug screening and therapy, including, for example, use of the gene in gene therapy to treat cardiovascular disease.